Skip to main content

Table 2 Sociodemographic, immunological and virological profile of chronically HIV-1 infected patients from Northwest Ethiopia

From: Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia

Variables Male no. (%) Female no. (%) Total no. (%)
  73 (45.4) 87 (54.1) 160 (100.0)
Age (years)    
<20 1 (1.4) 2 (2.3) 3 (1.9)
20–29 19 (26.0) 45 (51.7) 64 (40.0)
30–39 33 (45.2) 24 (27.6) 57 (35.6)
40–49 15 (20.6) 12 (13.8) 27 (16.9)
≥50 5 (6.8) 4 (4.6) 9 (5.6)
WHO clinical status    
I 6 (8.2) 13 (14.9) 19 (11.9)
II 13 (17.8) 15 (17.2) 28 (17.5)
III 49 (67.1) 57 (65.5) 106 (66.3)
IV 5 (6.8) 2 (2.3) 7 (4.4)
CD4+ T cell count (cells/mm3)    
<100 26 (35.6) 26 (29.9) 52 (32.5)
100–200 16 (21.9) 31 (35.6) 47 (29.4)
201–350 29 (39.7) 29 (33.3) 58 (36.3)
>350 2 (2.7) 1 (1.1) 3 (1.9)
HIV RNA level (copies/ml)    
103–104 13 (17.8) 16 (18.4) 29 (18.1)
104–105 28 (38.4) 38 (43.7) 66 (41.3)
105–106 29 (39.7) 28 (32.2) 57 (35.6)
>106 3 (4.1) 5 (5.7) 8 (5.0)